4 Parkinsons Disease Clinical Trials in Stanford, CA (2026)

Q: How do I join a clinical trial in Stanford?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you.

Recruiting Parkinsons Disease Studies in Stanford

NCT07174310Recruiting

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with early-stage Parkinson's disease (PD) on stable sympt...

Stanford, CAPHASE3900 participantsHoffmann-La Roche

View Study Details

NCT07567794Recruiting

GBPDC: Gut-Brain in PD Consortium Master Protocol

The purpose of this research study is to identify the role that the gut-brain axis, the group of nerves that connect the brain and gut, plays in Parkinson's disease (PD). The National Institute of Dia...

Stanford, CA250 participantsDuke University

View Study Details

NCT07217717Recruiting

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

This is a multi-site, open-label, non-randomized, single dose study to assess the clinical utility of \[¹⁸F\]FAPI-74 PET/CT in the detection of metastatic disease in individuals with pathologically co...

Stanford, CAPHASE3200 participantsSOFIE

View Study Details

NCT05968703Recruiting

Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease

The goal of this clinical trial is to evaluate the safety and tolerability of a novel deep brain stimulation (DBS) of the Subthalamic Nucleus (STN) and Nucleus Basalis of Meynert (NBM) to treat cognit...

Stanford, CANA10 participantsHelen M. Bronte-Stewart

View Study Details

About Parkinsons Disease Clinical Trials in Stanford

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 4 parkinsons disease clinical trials recruiting participants in Stanford, CA. These studies are seeking a combined 1,360 participants. Research is being sponsored by Hoffmann-La Roche, Duke University, SOFIE and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Stanford — FAQ

Are there parkinsons disease clinical trials in Stanford?

Yes, there are 4 parkinsons disease clinical trials currently recruiting in Stanford, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Stanford?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.

Are clinical trials in Stanford free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 4 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated September 2, 2026 from ClinicalTrials.gov